apremilast for psoriasis
Psoriasis treatments
apremilast for psoriasis
Psoriasis treatments

Apremilast

Apremilast is an oral medication used to treat moderate to severe plaque psoriasis by reducing inflammation inside the body that leads to redness, scaling, and plaque formation.
Apremilast is an oral phosphodiesterase-4 (PDE4) inhibitor that reduces inflammation associated with psoriasis and psoriatic arthritis. It helps decrease the severity of plaques and joint pain.
It is ideal for individuals with moderate to severe plaque psoriasis or psoriatic arthritis who prefer an oral medication over injections or topical treatments.
Improvements may begin within the first 2–4 weeks, with significant results typically seen by 16 weeks.
This treatment is prescribed for adults with plaque psoriasis who require systemic therapy or prefer an oral option instead of injections. It may also be suitable for patients who have not responded well to topical treatments alone. See pricing details here.

Real patients, real results

How effective is Apremilast

Clinically proven results

Reduced plaque severity and improved skin clarity with continued daily use.*
Clinical trials show that Apremilast helps decrease inflammation and psoriasis symptoms, leading to clearer skin and improved quality of life over time.
*Noticeable improvement may be seen within 12–16 weeks of consistent treatment.
Apremilast should be taken only as prescribed. For more information, see Important Safety Information.

How DermOnDemand Works

Common Question

Common side effects include nausea, diarrhea, and headaches, especially during the first few weeks of use. These symptoms usually improve over time.
Yes, it can be combined with topical therapies or biologics under a dermatologist’s supervision.
No routine lab tests are required, but your doctor may monitor your weight and mood, as the medication can sometimes cause weight loss or mood changes.